ArticleJournal of cancer research and clinical oncology2014

Efficacy and feasibility of cyclophosphamide combined with intermediate- dose or high-dose cytarabine for relapsed and refractory acute myeloid leukemia (AML).

Ulf Schnetzke et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.